Skip to main content

TREATING

CENTRAL SLEEP APNEA

Press Releases

ZOLL Medical Corporation acquires Respicardia, Inc.

ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, today announced that it has acquired Respicardia, Inc., a provider of novel implantable neurostimulators for the treatment of moderate to severe Central Sleep Apnea (CSA).

Read More